Skin Elements Raises AU$900,000 to Advance Growth Initiatives
Skin Elements Limited (ASX: SKN) has secured firm commitments to raise AU$900,000 through a placement to sophisticated and professional investors, strengthening its balance sheet and providing additional working capital. The company will issue 300 million new fully paid shares at AU$0.003 per share, representing a 25.0% discount to the last closing price and a 32.8% discount to the five-day volume-weighted average price. The proceeds will support the development of its product portfolio, including ECO Nurture, SuprCuvr, Soleo Organics sunscreen, and PapayaActivs skincare, while also funding general working capital and associated offer costs.
The placement is expected to settle on 16 July 2026, with Phoenix Global Investments acting as Sole Lead Manager. Alongside the capital raising, Skin Elements appointed Roderick Nicholas as Non-Executive Chairman and reduced annual non-executive director fees as part of a board remuneration review. The company also engaged Phoenix Global Investments to provide investor relations services under a 12-month agreement, with compensation partly in escrowed shares issued under existing placement capacity.
Customer Notice:
Nextgen Global Services Pty Ltd trading as Kapitales Research (ABN 89 652 632 561) is a Corporate Authorised Representative (CAR No. 1293674) of Enva Australia Pty Ltd (AFSL 424494). The information contained in this website is general information only. Any advice is general advice only. No consideration has been given or will be given to the individual investment objectives, financial situation or needs of any particular person. The decision to invest or trade and the method selected is a personal decision and involves an inherent level of risk, and you must undertake your own investigations and obtain your own advice regarding the suitability of this product for your circumstances. Please be aware that all trading activity is subject to both profit & loss and may not be suitable for you. The past performance of this product is not and should not be taken as an indication of future performance.
Kapitales Research, Level 13, Suite 1A, 465 Victoria Ave, Chatswood, NSW 2067, Australia | 1800 005 780 | info@kapitales.com.au
x
Daily Dose of Buy, Sell & Hold recommendations before the market opens.
Start Your 7 Days Free Trial Now!
We use cookies to help us improve, promote, and protect our services.
By continuing to use this site, we assume you consent to this.
Read our
Privacy Policy
and
Terms & Conditions
Skin Elements Raises AU$900,000 to Advance Growth Initiatives
Skin Elements Limited (ASX: SKN) has secured firm commitments to raise AU$900,000 through a placement to sophisticated and professional investors, strengthening its balance sheet and providing additional working capital. The company will issue 300 million new fully paid shares at AU$0.003 per share, representing a 25.0% discount to the last closing price and a 32.8% discount to the five-day volume-weighted average price. The proceeds will support the development of its product portfolio, including ECO Nurture, SuprCuvr, Soleo Organics sunscreen, and PapayaActivs skincare, while also funding general working capital and associated offer costs.
The placement is expected to settle on 16 July 2026, with Phoenix Global Investments acting as Sole Lead Manager. Alongside the capital raising, Skin Elements appointed Roderick Nicholas as Non-Executive Chairman and reduced annual non-executive director fees as part of a board remuneration review. The company also engaged Phoenix Global Investments to provide investor relations services under a 12-month agreement, with compensation partly in escrowed shares issued under existing placement capacity.
Customer Notice:
Nextgen Global Services Pty Ltd trading as Kapitales Research (ABN 89 652 632 561) is a Corporate Authorised Representative (CAR No. 1293674) of Enva Australia Pty Ltd (AFSL 424494). The information contained in this website is general information only. Any advice is general advice only. No consideration has been given or will be given to the individual investment objectives, financial situation or needs of any particular person. The decision to invest or trade and the method selected is a personal decision and involves an inherent level of risk, and you must undertake your own investigations and obtain your own advice regarding the suitability of this product for your circumstances. Please be aware that all trading activity is subject to both profit & loss and may not be suitable for you. The past performance of this product is not and should not be taken as an indication of future performance.
Kapitales Research, Level 13, Suite 1A, 465 Victoria Ave, Chatswood, NSW 2067, Australia | 1800 005 780 | info@kapitales.com.au